Form 4: 89bio Director Charles McWherter Acquires 10,000 Shares in Open Market Purchase

Director Charles McWherter of 89bio, Inc. purchased 10,000 shares of common stock at an average price of $8.00 per share.

Summary

• Charles McWherter, a director at 89bio, Inc., acquired 10,000 shares of the company's common stock.
• The purchase was made on December 5, 2024.
• The shares were bought at a weighted average price of $8.00 per share, with individual transaction prices ranging from $7.99 to $8.00.
• The transaction was an open market purchase.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as a director purchasing shares can be seen as a positive sign, but it's a routine transaction.

Positives

• The purchase by a director may signal confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical for directors and officers who are required to disclose their trades in company stock.
• The purchase of 10,000 shares is not unusual for a director's transaction.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

89bio, insider trading, stock purchase, Charles McWherter, director, ETNB, SEC Form 4